Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Keppel Corporation Ltd | KEP1 | Sep 19, 2024 | 4.55 | +1.83 |
KEPPEL REIT UTS | H27 | Sep 19, 2024 | 0.65 | +0.75 |
Kering | PPXB | Sep 19, 2024 | 23.40 | +3.54 |
Kering SA | PPX | Sep 19, 2024 | 234.95 | +3.05 |
Kerlink | 344 | Sep 19, 2024 | 0.51 | 0.00 |
Kernel Holding SA | 0KE | Sep 19, 2024 | 3.25 | +4.68 |
Kerry Group Plc | KRZ | Sep 19, 2024 | 89.95 | -0.06 |
Kerry Group Plc | KRZA | Sep 19, 2024 | 88.50 | -1.67 |
KERRY LOG NET | KYL | Sep 19, 2024 | 0.87 | +2.96 |
KERRY PPT | KR3 | Sep 19, 2024 | 1.60 | +1.27 |
KESKO A | KEK1 | Sep 19, 2024 | 18.26 | +0.22 |
Kesko B | KEK | Sep 19, 2024 | 18.23 | +0.16 |
Kesselrun Resources Ltd | CMG | Sep 19, 2024 | 0.03 | -29.17 |
Keurig Dr Pepper Inc. | DP5 | Sep 19, 2024 | 33.27 | +0.11 |
Kewpie Corporation | QPJ | Sep 19, 2024 | 22.20 | 0.00 |
Key Tronic Corporation | KT1 | Sep 19, 2024 | 4.54 | 0.00 |
KeyCorp | KEY | Sep 19, 2024 | 14.83 | +0.50 |
Keyence Corporation | KEE | Sep 19, 2024 | 429.10 | +3.67 |
Keyera Corp | K2Y | Sep 19, 2024 | 26.68 | +1.33 |
Keymed Biosciences Inc. | 64Z | Sep 19, 2024 | 4.22 | -4.09 |
Keyrus Progiware | 5UP | Sep 19, 2024 | 8.76 | +7.88 |
Keysight Technologies Inc | 1KT | Sep 19, 2024 | 136.76 | +1.71 |
Keyware Technologies NV | KY3A | Sep 19, 2024 | 0.63 | -3.82 |
Keywords Studios Plc | KS3 | Sep 19, 2024 | 28.60 | 0.00 |
Kezar Life Sciences, Inc. | 2KZ | Sep 19, 2024 | 0.48 | -0.42 |
Kforce, Inc. | ROF | Sep 19, 2024 | 56.00 | 0.00 |
KGHM Polska Miedz S.A. | KGHA | Sep 19, 2024 | 34.12 | +2.65 |
KGL Resources Limited | KN6 | Sep 19, 2024 | 0.04 | -15.09 |
KHD Humboldt Wedag International AG | KWG | Sep 19, 2024 | 1.28 | 0.00 |
Kiatnakin Phatra Bank Public Company Ltd | KIFF | Sep 19, 2024 | 1.34 | +1.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.